Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $25
What Makes BrightSpring Health Services, Inc. (BTSG) a Strong Momentum Stock: Buy Now?
BrightSpring Health Svcs Is Maintained at Overweight by Morgan Stanley
BrightSpring Health Analyst Ratings
Morgan Stanley Raises Price Target on BrightSpring Health Services to $25 From $20, Keeps Overweight Rating
Leerink Partners Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $28.5
BTIG Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $25
New Analyst Forecast: $BTSG Given $26.0 Price Target
Express News | Brightspring Health Services Inc : Mizuho Raises Target Price to $26 From $22
BrightSpring Health Services, Inc. (BTSG) Q1 2025 Earnings Call Transcript Summary
Update: BrightSpring Health Services Shares Rise After Q1 Beat
Sector Update: Health Care Stocks Rise Premarket Friday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell as Investors Weigh Mix of Earnings, Rise in US Nonfarm Payrolls
Sector Update: Health Care
10-Q: Q1 2025 Earnings Report
BrightSpring Health Raises FY2025 Sales Guidance From $11.60B-$12.10B To $12.00B-$12.50B Vs $11.96B Est; Sees Adjusted EBITDA Of $570M-$585M
BrightSpring Health Services Reports Strong Q1 2025 Financial Results and Raises Revenue and Adjusted EBITDA Guidance
8-K: BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Express News | Brightspring Health Services Inc - Increases 2025 Revenue Guidance to $12,000-$12,500 Million
BrightSpring Health Svcs 1Q EPS 14c >BTSG